SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
4324Signals sees a financing drought, in as much as the last "wet season" tuck5/2/2005
4323Myron: We don't deal with company-specific stuff here, unless it relates toscaram(o)uche5/1/2005
4322Myron: We don't deal with company-specific stuff here, unless it relates toscaram(o)uche5/1/2005
4321Richard, CEPH's drug Provigil has recently approved by the FDA to be prescifreelyhovering5/1/2005
4320Advanced Life Sciences Files IPO For Up To $86.25M In Stk DOW JONES NEWSWIRES Amopgcw4/29/2005
4319Receptor Biologix Raises $33.6 Million in Series A Financing to Fund Lead Producnigel bates4/28/2005
4318<i>$325 million devoted to buying drug royalty streams...</i> For tnigel bates4/25/2005
4317New fund targets drug royalties by Stacey Higginbotham in Austin Posted 02:26 ESSidney Street4/25/2005
4316 April 25, 2005 05:01 AM US Eastern Timezone Early-Stage Deals Gain Share in sim14/25/2005
4315BVF Inc Reports 12.08% Flamel Technologies Stake DOW JONES NEWSWIRES April 21, mopgcw4/25/2005
4314Synta Pharma Sets IPO At 6M Shares, $14-$16 A Share DOW JONES NEWSWIRES April 2mopgcw4/25/2005
4313sensational.... if management doesn't do everything it can to boost sharescaram(o)uche4/23/2005
4312Prestwick files for $74.75 million IPO Fri Apr 22, 2005 05:51 PM ET WASHINGTON,nigel bates4/23/2005
4311Not sure what Coley is doing beyond a recent cancer deal with Pfizer. dvax is lerkrw4/20/2005
4310Is one further along than the other? Going after same diseases? Also, cash/debRobohogs4/20/2005
4309Merely making an observation that 2 bios who are linked by a similar platform (arkrw4/20/2005
4308Is that a good thing, or a bad thing ? (...and if so, why ? <g> )nigel bates4/20/2005
4307Coley is raising more than Dynavax's entire market cap.rkrw4/20/2005
4306Coley Pharmaceutical files for $115 million IPO Wed Apr 20, 2005 07:02 AM ET Wnigel bates4/20/2005
43051. more cash in the bank, still with a clean balance sheet. 2. three new INDs scaram(o)uche4/18/2005
4304Biotech firm Galapagos to raise up to 40 mln eur in Brussels-Amsterdam IPO AMSTnigel bates4/15/2005
4303Interim Analysis of Phase III Trial Shows Avastin Plus Chemotherapy Improved Proscaram(o)uche4/15/2005
4302Thanks, Tuck, both for the link and the capsule. Very, very considerate. Rickscaram(o)uche4/12/2005
4301Signals is out with the March snapshot: signalsmag.com Notable is a lot more dtuck4/12/2005
4300Ambrx Completes $23.4 Million Private Placement Friday April 8, 8:00 am ET SANscaram(o)uche4/8/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News